Tue Jul 13, 3:46 pm ET
WASHINGTON (AFP) – British pharmaceutical giant GlaxoSmithKline hid the dangers of its top-selling diabetes drug Avandia and secretly wrote scientific articles about it, two US lawmakers charged Tuesday. The allegations came as the Food and Drug Administration (FDA) opened a two-day meeting of experts who will weigh whether to pull Avandia from the market over safety concerns. In a letter dated Monday and addressed to FDA Commissioner Margaret Hamburg, Senators Max Baucus and Charles Grassley accused Glaxo of covering up scientific studies that found problems with Avandia and of including the drug in a “ghostwriting” program.
If you know of a friend or loved one who is suffering with diabetes have them get in-touch with Creative Health Institute (CHI). We have seen 100’s of people bring their blood sugar back to normal in as less than 3 weeks.
Love and blessings,
Robert Morgan (Bobby)
Director of Health Education
Creative Health Institute
I don’t always agree with you (thank God, that would be boring), but I have to tell you you are a great writer.
LikeLike